FundedIQ
Biotechnology

EnPlusOne Biosciences: Funding, Investors & Team (Sep 2026)

EnPlusOne Biosciences offers cutting-edge solutions for up-and-coming RNA therapeutics.

www.enplusonebio.com LinkedIn Watertown, United States 11-50 employees
Biotechnology Life Science Therapeutics
Total raised
$10.0M
Rounds
1
Latest
Undisclosed round
Feb 2025

EnPlusOne Biosciences has raised $10.0M across 1 funding round on record, the most recent an undisclosed round of $10.0M announced in Feb 2025.

That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

EnPlusOne Biosciences Company Profile and Key Stats

Total funding raised
$10.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$10.0M in Feb 2025
Employees
11-50
reported band
Headquarters
Watertown, United States

Latest funding round on record: Feb 2025.

EnPlusOne Biosciences Funding Rounds

Date
Round
Amount
Undisclosed round
$10.0M

EnPlusOne Biosciences Founders and Leadership Team

Name
Role
Contact
Howon Lee
Founder

No contact details are on record for this team yet.

EnPlusOne Biosciences Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
29,722
$7.5M

EnPlusOne Biosciences' latest round of $10.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like EnPlusOne Biosciences in Biotechnology and Watertown

Companies Similar to EnPlusOne Biosciences

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…

Series A $6.3M

Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.

Series C $90.0M

Cataract surgery is the single most common procedure performed in the United States annually. Despite…

Series A $7.0M

InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…

Convertible Note $1.3M

Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…

Series A $10.0M

EnPlusOne Biosciences Funding FAQs

What does EnPlusOne Biosciences do?

EnPlusOne Biosciences offers cutting-edge solutions for up-and-coming RNA therapeutics.

How much funding has EnPlusOne Biosciences raised?

EnPlusOne Biosciences has raised $10.0M across 1 round on record. The most recent is an undisclosed round of $10.0M announced in Feb 2025.

When did EnPlusOne Biosciences last raise funding?

EnPlusOne Biosciences' most recent funding round on record is an undisclosed round of $10.0M, announced in Feb 2025.

Who founded EnPlusOne Biosciences?

FundedIQ lists Howon Lee (Founder) at EnPlusOne Biosciences.

Where is EnPlusOne Biosciences headquartered?

EnPlusOne Biosciences is based in Watertown, Massachusetts, United States.

How many employees does EnPlusOne Biosciences have?

EnPlusOne Biosciences is in the 11-50 employee band.

How does EnPlusOne Biosciences' funding compare to other Biotechnology startups?

EnPlusOne Biosciences' latest round of $10.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.

About FundedIQ's EnPlusOne Biosciences Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for EnPlusOne Biosciences is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.